BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

4:38 PM
 | 
Feb 05, 2010
 |  BC Extra  |  Company News

Par's Zuplenz receives complete response

FDA issued a complete response letter for an NDA from Par Pharmaceutical Cos. Inc. (NYSE:PRX) for Zuplenz ondansetron orally dissolving film strip to prevent nausea...

Read the full 117 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >